<?xml version='1.0' encoding='utf-8'?>
<document id="18199279"><sentence text="A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients."><entity charOffset="32-56" id="DDI-PubMed.18199279.s1.e0" text="tizanidine hydrochloride" /></sentence><sentence text="Tizanidine, one of the few oral antispastic therapies approved for use in the USA, has a narrow therapeutic index that can often make optimal patient dosing difficult"><entity charOffset="0-10" id="DDI-PubMed.18199279.s2.e0" text="Tizanidine" /></sentence><sentence text=" We surveyed the published literature for data on potential tizanidine dose relationships to pharmacokinetics, drug safety and effectiveness, as well as to provide practical drug dosing advice"><entity charOffset="60-70" id="DDI-PubMed.18199279.s3.e0" text="tizanidine" /></sentence><sentence text="" /><sentence text="The number of primary studies that describe tizanidine dose proportionality relationships was somewhat limited, even when including studies that used doses above those currently recommended or data from drug-drug interaction studies that resulted in supra-therapeutic tizanidine concentrations"><entity charOffset="44-54" id="DDI-PubMed.18199279.s5.e0" text="tizanidine" /><entity charOffset="268-278" id="DDI-PubMed.18199279.s5.e1" text="tizanidine" /><pair ddi="false" e1="DDI-PubMed.18199279.s5.e0" e2="DDI-PubMed.18199279.s5.e0" /><pair ddi="false" e1="DDI-PubMed.18199279.s5.e0" e2="DDI-PubMed.18199279.s5.e1" /></sentence><sentence text="" /><sentence text="There is substantial evidence to show that plasma tizanidine concentrations are linearly related to dose in healthy subjects and patients, although there is a high degree of intersubject variability"><entity charOffset="50-60" id="DDI-PubMed.18199279.s7.e0" text="tizanidine" /></sentence><sentence text=" The most common adverse events and pharmacodynamic effects are related to plasma concentrations" /><sentence text=" The clinical implications of the large interpatient variability in plasma tizanidine concentrations and its narrow therapeutic index make it necessary to individualise patient therapy"><entity charOffset="75-85" id="DDI-PubMed.18199279.s9.e0" text="tizanidine" /></sentence><sentence text=" Practical advice on tizanidine dosing and/or switching between formulations is provided"><entity charOffset="21-31" id="DDI-PubMed.18199279.s10.e0" text="tizanidine" /></sentence><sentence text="" /></document>